Tokyo Tape
Sign in
← Towa Pharmaceutical

Quarterly report · Q3

4553.TEDINET S100Q7FF
Period2022-04-01 → 2022-12-31
Filed2023-02-14
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 35
MetricValuePeriodScopeSource row
Revenue¥140.4bn2022-04-01 → 2022-12-31Cons.Net sales
Revenue¥165.6bn2021-04-01 → 2022-03-31Cons.Net sales (5-year summary)
Revenue¥125.6bn2021-04-01 → 2021-12-31Cons.Net sales
Operating income¥5.4bn2022-04-01 → 2022-12-31Cons.Operating income
Operating income¥17.0bn2021-04-01 → 2021-12-31Cons.Operating income
Ordinary income¥4.6bn2022-04-01 → 2022-12-31Cons.Ordinary income
Ordinary income¥22.7bn2021-04-01 → 2022-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥21.1bn2021-04-01 → 2021-12-31Cons.Ordinary income
Profit before tax¥4.2bn2022-04-01 → 2022-12-31Cons.Income before income taxes
Profit before tax¥21.1bn2021-04-01 → 2021-12-31Cons.Income before income taxes
Net income (owners)¥2.0bn2022-04-01 → 2022-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥15.9bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥15.0bn2021-04-01 → 2021-12-31Cons.Profit loss attributable to owners of parent
Net income¥2.0bn2022-04-01 → 2022-12-31Cons.Profit loss
Net income¥15.0bn2021-04-01 → 2021-12-31Cons.Profit loss
Total assets¥357.3bnat 2022-12-31Cons.Assets
Total assets¥332.1bnat 2022-03-31Cons.Assets
Total assets¥256.0bnat 2021-12-31Cons.Total assets (5-year summary)
Total liabilities¥219.6bnat 2022-12-31Cons.Liabilities
Total liabilities¥199.9bnat 2022-03-31Cons.Liabilities
Net assets / equity¥137.7bnat 2022-12-31Cons.Net assets
Net assets / equity¥132.2bnat 2022-03-31Cons.Net assets
Net assets / equity¥130.7bnat 2021-12-31Cons.Net assets (5-year summary)
Cash and deposits¥16.6bnat 2022-12-31Cons.Cash and deposits
Cash and deposits¥32.8bnat 2022-03-31Cons.Cash and deposits
EPS (basic)¥40.322022-04-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-14.382022-10-01 → 2022-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥323.362021-04-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥304.82021-04-01 → 2021-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥117.012021-10-01 → 2021-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥316.192021-04-01 → 2022-03-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥298.052021-04-01 → 2021-12-31Cons.Diluted earnings per share (5-year summary)
Equity ratio38.6%at 2022-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio39.8%at 2022-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio51.0%at 2021-12-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 24
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-12-31−¥140m
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-12-31−¥140m
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-12-31−¥3.1bn
jpcrp040300-q3r_E00974-000Domesticreportable segmentrevenue2022-04-01 → 2022-12-31¥110.0bn
jpcrp040300-q3r_E00974-000Domesticreportable segmentrevenue external2022-04-01 → 2022-12-31¥110.0bn
jpcrp040300-q3r_E00974-000Domesticreportable segmentsegment profit2022-04-01 → 2022-12-31¥8.2bn
jpcrp040300-q3r_E00974-000Overseasreportable segmentrevenue2022-04-01 → 2022-12-31¥30.5bn
jpcrp040300-q3r_E00974-000Overseasreportable segmentrevenue external2022-04-01 → 2022-12-31¥30.4bn
jpcrp040300-q3r_E00974-000Overseasreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥140m
jpcrp040300-q3r_E00974-000Overseasreportable segmentsegment profit2022-04-01 → 2022-12-31¥185m
—segment totalrevenue2022-04-01 → 2022-12-31¥140.5bn
—segment totalrevenue external2022-04-01 → 2022-12-31¥140.4bn
—segment totalrevenue intersegment2022-04-01 → 2022-12-31¥140m
—segment totalsegment profit2022-04-01 → 2022-12-31¥8.4bn
Reconciling Itemsreconcilingsegment profit2021-04-01 → 2021-12-31−¥600m
jpcrp040300-q3r_E00974-000Domesticreportable segmentrevenue2021-04-01 → 2021-12-31¥97.8bn
jpcrp040300-q3r_E00974-000Domesticreportable segmentrevenue external2021-04-01 → 2021-12-31¥97.8bn
jpcrp040300-q3r_E00974-000Domesticreportable segmentsegment profit2021-04-01 → 2021-12-31¥17.0bn
jpcrp040300-q3r_E00974-000Overseasreportable segmentrevenue2021-04-01 → 2021-12-31¥27.8bn
jpcrp040300-q3r_E00974-000Overseasreportable segmentrevenue external2021-04-01 → 2021-12-31¥27.8bn
jpcrp040300-q3r_E00974-000Overseasreportable segmentsegment profit2021-04-01 → 2021-12-31¥629m
—segment totalrevenue2021-04-01 → 2021-12-31¥125.6bn
—segment totalrevenue external2021-04-01 → 2021-12-31¥125.6bn
—segment totalsegment profit2021-04-01 → 2021-12-31¥17.6bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 359
ItemContextValueUnit
Revenues from external customersCurrentYTDDuration140405000000JPY
Transactions with other segmentsCurrentYTDDuration_jpcrp040300-q3r_E00974-000DomesticReportableSegmentsMember－JPY
Transactions with other segmentsCurrentYTDDuration_jpcrp040300-q3r_E00974-000OverseasReportableSegmentsMember140000000JPY
Transactions with other segmentsCurrentYTDDuration_ReportableSegmentsMember140000000JPY
Transactions with other segmentsCurrentYTDDuration_ReconcilingItemsMember-140000000JPY
Transactions with other segmentsCurrentYTDDuration－JPY
Net salesCurrentYTDDuration_jpcrp040300-q3r_E00974-000DomesticReportableSegmentsMember110005000000JPY
Net salesCurrentYTDDuration_jpcrp040300-q3r_E00974-000OverseasReportableSegmentsMember30540000000JPY
Net salesCurrentYTDDuration_ReportableSegmentsMember140545000000JPY
Net salesCurrentYTDDuration_ReconcilingItemsMember-140000000JPY
Net salesCurrentYTDDuration140405000000JPY
Operating incomeCurrentYTDDuration_jpcrp040300-q3r_E00974-000DomesticReportableSegmentsMember8245000000JPY
Operating incomeCurrentYTDDuration_jpcrp040300-q3r_E00974-000OverseasReportableSegmentsMember185000000JPY
Operating incomeCurrentYTDDuration_ReportableSegmentsMember8431000000JPY
Operating incomeCurrentYTDDuration_ReconcilingItemsMember-3079000000JPY
Operating incomeCurrentYTDDuration5352000000JPY
Document title cover pageFilingDateInstant
Original text (Japanese)四半期報告書
Clause of stipulation cover pageFilingDateInstant
Original text (Japanese)金融商品取引法第24条の4の7第1項
Place of filing cover pageFilingDateInstant
Original text (Japanese)近畿財務局長
Filing date cover pageFilingDateInstant2023-02-14
Quarterly accounting period cover pageFilingDateInstant
Original text (Japanese)第67期第3四半期（自　2022年10月1日　至　2022年12月31日）
Company name cover pageFilingDateInstant
Original text (Japanese)東和薬品株式会社
Company name in english cover pageFilingDateInstantTOWA PHARMACEUTICAL CO., LTD.
Title and name of representative cover pageFilingDateInstant
Original text (Japanese)代表取締役社長　　吉田　逸郎
Address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)大阪府門真市新橋町2番11号
Telephone number address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)06（6900）9100（代表）
Name of contact person address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)取締役　　田中　政男
Nearest place of contact cover pageFilingDateInstant
Original text (Japanese)大阪府門真市新橋町2番11号
Telephone number nearest place of contact cover pageFilingDateInstant
Original text (Japanese)06（6900）9100（代表）
Name of contact person nearest place of contact cover pageFilingDateInstant
Original text (Japanese)取締役　　田中　政男
Place for public inspection cover page (text)FilingDateInstantText · Plus
Edinet codeFilingDateInstantE00974
Fund codeFilingDateInstant－
Security codeFilingDateInstant45530
Filer name in japaneseFilingDateInstant
Original text (Japanese)東和薬品株式会社
Filer name in englishFilingDateInstantTOWA PHARMACEUTICAL CO., LTD.
Fund name in japaneseFilingDateInstant－
Fund name in englishFilingDateInstant－
Cabinet office ordinanceFilingDateInstant
Original text (Japanese)企業内容等の開示に関する内閣府令
Document typeFilingDateInstant
Original text (Japanese)第四号の三様式
Accounting standardsFilingDateInstantJapan GAAP
Whether consolidated financial statements are preparedFilingDateInstanttrue
Industry code when consolidated financial statements are prepared in accordance with industry specific regulationsFilingDateInstantCTE
Industry code when financial statements are prepared in accordance with industry specific regulationsFilingDateInstant－
Current fiscal year start dateFilingDateInstant2022-04-01
Current period end dateFilingDateInstant2022-12-31
Type of current periodFilingDateInstantQ3
Current fiscal year end dateFilingDateInstant2023-03-31
Previous fiscal year start dateFilingDateInstant2021-04-01
Comparative period end dateFilingDateInstant2021-12-31

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-03-31pass rounding
balance sheet identityconsolidated 2022-12-31pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-03-31pass
statement vs summary · net assetsconsolidated 2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-12-31pass
statement vs summary · revenueconsolidated 2021-04-01/2021-12-31pass
statement vs summary · revenueconsolidated 2022-04-01/2022-12-31pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-12-31pass